KCT0005510
Recruiting
未知
A 8 weeks, multi-center, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of enzyme-treated Zizania latifolia (Griseb.) Turcz. ex Stapf extract powder on improvement of Liver function
Wonkwang University Oriental Medical Hospital, Jeonju0 sites100 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Wonkwang University Oriental Medical Hospital, Jeonju
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 5 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\)Males and females aged over 19 years at the screening examination
- •2\)Participants with 46 U/L\=Alanine Transaminase(ALT), 65 U/L\=Gamma\-glutamyl transferase(GGT)
- •3\)Participants who consume alcohol more than 14 unit/weeks for men and 7 unit/weeks for women
- •4\)Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions
Exclusion Criteria
- •1\) GGT, ALT or AST \> 3\-fold of normal range
- •2\) Individual with cirrosis, liver cancer or sign of liver cancer
- •3\) Taking the liver function improving supplements or medicine within previous 1 month
- •4\) Participation in other clinical trials within the previous 3 months
- •5\) Laboratory test, medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A human trial of Agrimonia pilosa extract powder on improvement of Liver functioKCT0008689Wonkwang University, Gwangju Medical Center100
Recruiting
Not Applicable
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of Magnolia extract on gingival healthKCT0006746O100
Completed
Not Applicable
A 8 week, multi-center, randomized, double-blind, placebo-controlled clinical trial for the evaluation of the efficacy and safety of MAEC on gingival healthCongenital malformations, deformations and chromosomal abnormalitiesKCT0005569MedibioLAB100
Active, not recruiting
Not Applicable
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioEUCTR2006-000774-70-GBovartis Pharma Services AG2,252
Active, not recruiting
Not Applicable
An 8-week, multicenter, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of the combination of valsartan/HCTZ/amlodipine compared to valsartan/HCTZ, valsartan/amlodipine, and HCTZ/amlodipine in patients with moderate to severe hypertensioEUCTR2006-000774-70-SEovartis Pharma Services AG2,252